1732: A PHASE II MULTICENTRIC RANDOMIZED CONTROLLED STUDY OF CENTHAQUINE IN HEMORRHAGIC SHOCK PATIENTS : Critical Care Medicine

Journal Logo

Advanced Search
Research Snapshot Theater: Shock III

1732: A PHASE II MULTICENTRIC RANDOMIZED CONTROLLED STUDY OF CENTHAQUINE IN HEMORRHAGIC SHOCK PATIENTS

Gulati, Anil1; Jain, Dinesh2; Agrawal, Nilesh3; Rahate, Prashant4; Das, Soumen5; Chowdhuri, Rajat5; Prabhu, Madhav6; Haveri, Sameer6; Dhibar, Deba7; Lavhale, Manish8

Author Information

1Pharmazz, Inc., Willowbrook, IL

2Dayanand Medical College, Ludhiana, India

3New Era Hospital, Nagpur, India

4Seven Star Hospital, Nagpur, India

5Institute of Post Graduate Medical Education and Research, Kolkata, India

6KLE’s Dr. Prabhakar Kore Hospital and Medical Research Centre, Belgaum, India

7Post Graduate Institute of Medical Education and Research, Chandigarh, India

8Pharmazz India Private Limited, Greater Noida, India

Critical Care Medicine 48(1):p 840, January 2020. | DOI: 10.1097/01.ccm.0000649224.29144.8f
Copyright © 2019 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Full Text Access for Subscribers:

Log in with your SCCM credentials.
Log in with your SCCM credentials.

Not a Subscriber?

Buy
Request Permissions
Become a Society Member

You can read the full text of this article if you:

Access through Ovid